Surgery Partners, Inc.
Surgery Partners, Inc.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||
Assets Current | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 217 | 182 | 240 | 203 | 250 | 229 | 270 | 222 | 214 | 185 | 196 | 236 | |||||
Accounts Receivable Net Current | 617 | 603 | 602 | 579 | 563 | 571 | 579 | 543 | 523 | 494 | 496 | 463 | |||||
Inventory Net | 99 | 101 | 97 | 92 | 87 | 88 | 88 | 82 | 81 | 77 | 75 | 69 | |||||
Prepaid Expense Current | 48 | 39 | 41 | 45 | 46 | 36 | 36 | 45 | 45 | 32 | 31 | 35 | |||||
Other Assets Current | 146 | 158 | 171 | 183 | 159 | 150 | 146 | 144 | 150 | 108 | 97 | 73 | |||||
Assets Current | 1,126 | 1,083 | 1,151 | 1,102 | 1,105 | 1,075 | 1,119 | 1,036 | 1,013 | 896 | 895 | 876 | |||||
Property Plant And Equipment And Finance Lease Rig… | - | 1,135 | 1,153 | 1,164 | 1,180 | 1,151 | 1,088 | 1,005 | 1,006 | 983 | 969 | 940 | |||||
Intangible Assets Net Excluding Goodwill | - | - | 41 | - | - | - | 46 | - | - | - | 55 | - | |||||
Goodwill | - | - | 5,195 | - | - | - | 5,068 | - | - | - | 4,326 | - | |||||
Intangible Assets Net Including Goodwill | 5,242 | 5,245 | - | 5,135 | 5,140 | 5,171 | - | 4,862 | 4,859 | 4,451 | - | 4,301 | |||||
Investments In Affiliates Subsidiaries Associates … | 227 | 225 | 234 | 229 | 220 | 219 | 215 | 215 | 227 | 189 | 184 | 196 | |||||
Operating Lease Right Of Use Asset | 279 | 282 | 289 | 276 | 272 | 278 | 296 | 298 | 267 | 258 | 255 | 245 | |||||
Other Assets Noncurrent | 54 | 73 | 57 | 41 | 38 | 56 | 58 | 41 | 36 | 112 | 103 | 117 | |||||
Deferred Income Tax Assets Net | - | - | - | - | - | - | 0 | 79 | 82 | 87 | 90 | 105 | |||||
Assets | 8,050 | 8,042 | 8,120 | 7,947 | 7,955 | 7,949 | 7,890 | 7,534 | 7,489 | 6,976 | 6,877 | 6,780 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Liabilities Current | |||||||||||||||||
Accounts Payable Current | 175 | 169 | 209 | 175 | 175 | 165 | 209 | 171 | 174 | 174 | 172 | 149 | |||||
Employee Related Liabilities Current | 73 | 77 | 65 | 70 | 59 | 67 | 60 | 65 | 63 | 69 | 74 | 82 | |||||
Other Liabilities Current | 227 | 236 | 243 | 239 | 229 | 234 | 254 | 242 | 222 | 204 | 204 | 208 | |||||
Long Term Debt And Capital Lease Obligations Curre… | 103 | 100 | 99 | 103 | 110 | 104 | 101 | 97 | 92 | 77 | 73 | 62 | |||||
Liabilities Current | 579 | 582 | 616 | 586 | 573 | 569 | 624 | 575 | 552 | 523 | 523 | 501 | |||||
Long Term Debt And Capital Lease Obligations | 3,648 | 3,614 | 3,603 | 3,461 | 3,465 | 3,447 | 3,269 | 3,094 | 3,040 | 2,794 | 2,702 | 2,640 | |||||
Operating Lease Liability Noncurrent | 266 | 272 | 280 | 266 | 264 | 273 | 292 | 286 | 258 | 251 | 249 | 241 | |||||
Deferred Income Tax Liabilities Net | 54 | 52 | 53 | 43 | 37 | 39 | 39 | - | - | - | 0 | - | |||||
Other Liabilities Noncurrent | 34 | 42 | 41 | 38 | 36 | 35 | 30 | 30 | 21 | 46 | 41 | 79 | |||||
Redeemable Noncontrolling Interest Equity Carrying… | 367 | 383 | 396 | 411 | 422 | 431 | 439 | 436 | 442 | 324 | 327 | 332 | |||||
Stockholders Equity Inclu… | |||||||||||||||||
Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Value Outstanding | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Additional Paid In Capital | 2,544 | 2,548 | 2,541 | 2,543 | 2,538 | 2,526 | 2,521 | 2,514 | 2,511 | 2,496 | 2,498 | 2,495 | |||||
Accumulated Other Comprehensive Income Loss Net Of… | -9 | -11 | -14 | -14 | -13 | -12 | 5 | 11 | 37 | 52 | 58 | 77 | |||||
Retained Earnings Accumulated Deficit | -866 | -851 | -815 | -800 | -778 | -775 | -737 | -629 | -597 | -582 | -569 | -568 | |||||
Stockholders Equity | 3,102 | 3,098 | 3,131 | 3,142 | 3,157 | 1,740 | 3,196 | 1,897 | 1,952 | 1,967 | 1,987 | 2,005 | |||||
Minority Interest | 1,431 | 1,410 | 1,418 | 1,413 | 1,408 | 1,416 | 1,407 | 1,215 | 1,224 | 1,071 | 1,047 | 982 | |||||
Liabilities And Stockholders Equity | 8,050 | 8,042 | 8,120 | 7,947 | 7,955 | 7,949 | 7,890 | 7,534 | 7,489 | 6,976 | 6,877 | 6,780 | |||||
Property Plant And Equipment And Finance Lease Rig… | - | 686 | - | 620 | 589 | 587 | - | 559 | 519 | 485 | - | 426 | |||||
Preferred Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |||||
Preferred Stock Shares Authorized | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | |||||
Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |||||
Common Stock Shares Authorized | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | |||||
Common Stock Shares Issued | 131 | 131 | 129 | 129 | 128 | 128 | 127 | 127 | 127 | 127 | 127 | 126 | |||||
Shares Outstanding | 131 | 131 | 129 | 129 | 128 | 128 | 127 | 127 | 127 | 127 | 127 | 126 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -6.31% | 10.94% | 10.31% | - | - | - | - | - | - | - | - | - |
| 2025 | -0.30% | -4.77% | -8.51% | 2.48% | -1.31% | 2.98% | 7.20% | -4.83% | -7.33% | -27.64% | -9.70% | -15.62% |
| 2024 | -0.61% | -14.33% | 15.30% | 7.79% | 7.69% | -0.57% | -25.97% | -28.71% | -13.80% | -0.42% | -10.69% | -5.20% |
| 2023 | - | - | - | - | - | - | 20.40% | 13.12% | 11.99% | -7.91% | -21.09% | -14.47% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Metrics | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Metric history beyond 3 years is for subscribers only. Unlock 17+ years of history across 90+ calculated metrics Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 1.95 | 1.86 | 1.87 | 1.88 | 1.93 | 1.89 | 1.79 | 1.80 | 1.83 | 1.71 | 1.71 | 1.75 | |||||
| Quick Ratio | 1.69 | 1.62 | 1.65 | 1.65 | 1.70 | 1.67 | 1.59 | 1.58 | 1.61 | 1.50 | 1.51 | 1.54 | |||||
| Working Capital | 547.50M | 500.80M | 535.20M | 516.20M | 532.00M | 505.20M | 495.00M | 460.60M | 460.70M | 372.50M | 372.00M | 374.80M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | 0.19 | 0.19 | 0.20 | 0.19 | 0.18 | 0.33 | 0.20 | 0.30 | 0.28 | 0.27 | 0.17 | 0.25 | |||||
| Interest Coverage TTM | 1.36 | 1.41 | 1.43 | 1.58 | 1.55 | 1.55 | 1.73 | 1.64 | 1.75 | 1.85 | 1.70 | 1.56 | |||||
| Debt Ratio | 0.07 | 0.07 | 0.08 | 0.07 | 0.07 | 0.07 | 0.08 | 0.08 | 0.07 | 0.08 | 0.08 | 0.07 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.42 | 0.42 | 0.41 | 0.42 | 0.42 | 0.43 | 0.42 | 0.42 | 0.41 | 0.41 | 0.40 | 0.41 | |||||
| Days Sales Outstanding TTM | 63.96 | 64.08 | 65.16 | 62.29 | 61.26 | 61.25 | 63.02 | 61.48 | 61.48 | 61.86 | 63.38 | 59.50 | |||||
| Receivables Turnover TTM | 5.71 | 5.70 | 5.60 | 5.86 | 5.96 | 5.96 | 5.79 | 5.94 | 5.94 | 5.90 | 5.76 | 6.13 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | 0.95 | 1.05 | 0.78 | -1.64 | -1.71 | -1.82 | -1.33 | -0.19 | 0.02 | 0.30 | -0.09 | -0.78 | |||||
| Free Cash Flow Per Share TTM | 1.46 | 1.62 | 1.54 | 1.53 | 1.38 | 1.37 | 1.66 | 1.30 | 1.62 | 1.39 | 1.63 | 1.17 | |||||
| Dividend Per Share TTM | 1.65 | 1.73 | 1.78 | 1.71 | 1.62 | 1.52 | 1.35 | 1.25 | 1.19 | 1.15 | 1.16 | 1.17 | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | 70.36% | 70.70% | 70.65% | 70.89% | 70.87% | 70.66% | 70.86% | 70.92% | 71.10% | 71.13% | 71.06% | 70.81% | |||||
| Operating Profit Margin TTM | 11.40% | 11.77% | 11.77% | 12.36% | 11.17% | 10.55% | 11.20% | 10.82% | 11.93% | 12.80% | 11.96% | 11.82% | |||||
| Net Profit Margin TTM | 3.62% | 4.02% | 2.99% | -6.33% | -6.71% | -7.25% | -5.40% | -0.80% | 0.10% | 1.33% | -0.43% | -3.63% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | 3.99% | 5.38% | 6.24% | 10.14% | 12.05% | 13.54% | 13.52% | 9.96% | 8.55% | 7.10% | 8.03% | 11.16% | |||||
| Net Income Growth (1Y) | -156.20% | -158.45% | -158.83% | 770.71% | -7,586.21% | -716.89% | 1,312.61% | -75.76% | -102.44% | -130.50% | -78.21% | -398.79% | |||||
| EPS Growth (1Y) | -155.39% | -157.65% | -158.33% | 763.63% | -7,536.33% | -713.82% | 1,306.90% | -75.84% | -102.44% | -130.31% | -84.05% | -311.25% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | 17.74 | 11.38 | 19.87 | -13.23 | -13.00 | -13.07 | -15.88 | -170.20 | 1,034.73 | 100.74 | -337.68 | -37.30 | |||||
| P/B TTM | 0.70 | 0.49 | 0.63 | 0.88 | 0.89 | 1.73 | 0.84 | 2.14 | 1.54 | 1.91 | 1.32 | 1.83 | |||||
| P/S TTM | 0.64 | 0.46 | 0.59 | 0.84 | 0.87 | 0.95 | 0.86 | 1.36 | 1.04 | 1.34 | 1.46 | 1.35 | |||||
| Market Cap | 2.16B | 1.53B | 1.97B | 2.75B | 2.82B | 3.01B | 2.67B | 4.07B | 3.00B | 3.76B | 4.02B | 3.68B | |||||
| Enterprise Value | 5.70B | 5.06B | 5.43B | 6.11B | 6.15B | 6.33B | 5.77B | 7.04B | 5.92B | 6.44B | 6.60B | 6.14B | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | 187.60M | 208.00M | 195.60M | 194.10M | 175.30M | 173.30M | 209.70M | 163.40M | 204.10M | 174.50M | 205.00M | 146.70M | |||||
| Net Debt | 3.53B | 3.53B | 3.46B | 3.36B | 3.33B | 3.32B | 3.10B | 2.97B | 2.92B | 2.69B | 2.58B | 2.47B | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
| NCAV | |||||||||||||||||
| NCAV Per Share TTM | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
Surgery Partners, Inc. (SGRY) — SEC Financial Statements & Analysis
Surgery Partners, Inc. (SGRY) is a services-general medical & surgical hospitals, nec company, incorporated in DE. Surgery Partners, Inc. trades on Nasdaq as: SGRY. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Surgery Partners, Inc. reported a 3.99% year-over-year revenue growth, a Gross Profit Margin of 70.36% (TTM), a Debt-to-Equity ratio of 0.19x, a Price-to-Sales (P/S) ratio of 0.64x (TTM), a Price-to-Book (P/B) ratio of 0.70x (TTM), at a market cap of $2.16B. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- 3.99%
- Gross Profit Margin TTM
- 70.36%
- Debt To Equity
- 0.19x
- P/S TTM
- 0.64x
- P/B TTM
- 0.70x
- Market Cap
- $2.16B
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Surgery Partners, Inc. in?
Surgery Partners, Inc. (SGRY) operates in the Services-General Medical & Surgical Hospitals, NEC industry.
What is SGRY's market cap?
Surgery Partners, Inc. (SGRY) has a market capitalization of $2.16B as of 2026-06-30.
What is SGRY's P/E ratio?
Surgery Partners, Inc. (SGRY)'s trailing twelve month P/E ratio is 17.74x as of 2026-06-30.
What exchange does SGRY trade on?
Surgery Partners, Inc. (SGRY) trades on the Nasdaq.
Where is Surgery Partners, Inc. incorporated?
Surgery Partners, Inc. is incorporated in DE.